Jane Street’s Lantern Pharma LTRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8K Buy
+11,670
New +$28.1K ﹤0.01% 11394
2024
Q2
– Sell
-24,872
Closed -$150K – 9850
2024
Q1
$219K Buy
+24,872
New +$133K ﹤0.01% 8057
2023
Q1
– Sell
-15,134
Closed -$91.4K – 9539
2022
Q4
$91.4K Buy
+15,134
New +$75.8K ﹤0.01% 8144

Other funds holding LTRN

Jane Street's LTRN Position: Q3 2026 in Review

Jane Street opened a new position in Lantern Pharma (LTRN) in Q3 2026: 11,670 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #11394 among its holdings. This is a return to the name: Jane Street previously reported a position in LTRN as recently as Q1 2024.

Jane Street first reported a position in LTRN in Q4 2022 and has held it in 3 quarters since. The position peaked at $219K in Q1 2024. 43 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

  • Jane Street held 11,670 shares of Lantern Pharma worth $11.8K as of Q3 2026.
  • Lantern Pharma was a new Jane Street position in Q3 2026.
  • Lantern Pharma made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11394 holding.
  • Jane Street first reported a position in Lantern Pharma in Q4 2022 and has held it in 3 quarters since.
  • Jane Street's Lantern Pharma position peaked at $219K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.